Image

Thoracic Paravertebral Block vs Intrathecal Morphine in VATS

Thoracic Paravertebral Block vs Intrathecal Morphine in VATS

Recruiting
18-75 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to find out which pain relief method works better for people having video-assisted thoracoscopic surgery. We will compare two techniques: thoracic paravertebral block (TPVB), a numbing injection near the spine, and intrathecal morphine (ITM), a small dose of morphine injected into the spinal fluid. We want to see if ITM works as well as TPVB in reducing the need for pain medicine during the first 24 hours after surgery. People in the study will get either TPVB or ITM before going to sleep for surgery, use a patient-controlled pain pump after surgery, and have their pain scores, medicine use, recovery, and possible side effects checked for up to 30 days after surgery.

Description

This study will compare two different pain control techniques for people having video-assisted thoracoscopic surgery (VATS), a minimally invasive chest operation. The first technique, called thoracic paravertebral block (TPVB), involves injecting numbing medicine near the spine to block pain from the surgical area. The second technique, intrathecal morphine (ITM), involves giving a small dose of morphine into the spinal fluid to provide pain relief after surgery.

The main goal is to find out if ITM works as well as TPVB in reducing the need for additional pain medicine during the first 24 hours after surgery. This is a randomized controlled trial, meaning participants will be randomly assigned to one of the two groups. Everyone will receive general anesthesia for their surgery and will use a patient-controlled analgesia pump afterwards, along with regular pain medicines such as paracetamol and tenoxicam.

Pain scores, the amount of pain medicine used, and recovery quality will be measured at regular times in the first 24 hours after surgery. We will also monitor side effects such as nausea, vomiting, itching, or breathing problems. All patients will be followed for 30 days after surgery to check for any complications.

Eligibility

Inclusion Criteria

  1. Age between 18 and 75 years
  2. American Society of Anesthesiologists (ASA) physical status I-III
  3. Scheduled for elective video-assisted thoracoscopic surgery (VATS) for wedge resection, segmentectomy, or lobectomy
  4. Ability to understand the study protocol and provide written informed consent

Exclusion Criteria

  1. Refusal to participate
  2. Pregnancy
  3. Morbid obesity (body mass index > 30)
  4. Known allergy to opioids, local anesthetics, or NSAIDs
  5. History of neuropsychiatric disorder, cognitive impairment, or inability to communicate with investigators
  6. History of substance abuse
  7. Current anticoagulant use or known bleeding disorder
  8. Presence of systemic infection
  9. Significant cardiovascular, hepatic, renal, or endocrine disease
  10. History of chronic pain syndromes or chronic pain treatment
  11. Emergency surgery or previous ipsilateral VATS or thoracotomy
  12. Preoperative chronic opioid therapy within 3 months (≥15 mg/day for ≥30 days)
  13. Severe intraoperative or postoperative bleeding, hemodynamic instability
  14. Requirement for prolonged postoperative ventilation (> 18 hours)

Study details
    Postoperative Acute Pain
    Video-Assisted Thoracoscopic Surgery
    Intrathechal Morphine
    Paravertebral Peripheral Nerve Block

NCT07126483

Ondokuz Mayıs University

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.